Nearly a year after the World Health Organization (WHO) declared the novel coronavirus for the first time as a public health emergency, the agency issued new clinical advice for both home and hospital treatment of COVID-19 patients.
The agency also announced upcoming plans to study so-called “long-COVID” or otherwise “COVID long-throwers” who are still suffering from symptoms after the infection has disappeared.
The agency also unveiled plans to study COVID.
(iStock)
“Understanding this condition is one of the WTO’s key areas of work,” the agency said in a news release on Tuesday. “In February 2021, the WHO will organize a series of consultations to reach consensus on a description of this condition and the subtypes, and definitions of cases. The scientific understanding will inform the name of the condition. The consultations will be a wide range. stakeholders, including patient groups. “
OUR PROMISE TO HELP IN CORONAVIRUS ANSWER: FAUCI
Meanwhile, the WHO recommends that pulse oximetry be used to measure oxygen levels in the blood for current patients who do not require hospitalization. The products available over the counter should be “coordinated with other aspects of home care, such as education for the patent and care provider and regular follow-up of the patient.”
For those in need of hospitalization, the agency suggests that healthcare providers consider using low-dose anticoagulants to prevent blood clots, as well as placing patients receiving non-invasive supplemental oxygen on their stomachs to increase oxygen flow.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
The agency noted that the guidelines are a live document that is updated regularly as more data becomes available. ‘The update comes on the same day that the WTO announced that it was working with Moderna to speed up the approval of its COVID-19 survey for emergency use.